Australian women sue over pelvic implants
MORE than 700 Australian women in a class-action case against pharmaceutical giant Johnson & Johnson that started yesterday argued that the company’s vaginal mesh implants caused them devastating pain, ravaged their bodies and, in some cases, ruined their lives.
Patients across the United States, United Kingdom and Canada have filed tens of thousands of lawsuits against Johnson & Johnson and other pelvic mesh manufacturers over the devices, which are used to treat urinary incontinence and repair pelvic organ prolapse, a condition often caused by childbirth in which organs shift out of place.
Women who have sued the manufacturers say the mesh caused them chronic and often debilitating pain, infections, loss of sexual function and incontinence.
In 2014, Irish medical device maker Endo International said it would pay US$830 million to settle more than 20,000 personal injury lawsuits related to its vaginal mesh implants.
The Australian trial that began yesterday is expected to last six months. The lawsuit argues the US-based company was negligent for not properly warning doctors and patients about the risks associated with the devices. The lawsuit also contends that the products were not fit for the purposes for which they were designed, and the testing before the devices went on the market was inadequate.
Gai Thompson, one of the claimants in the lawsuit, said she has suffered pain every day since she received the implant.
“No amount of compensation, money, could ever replace what we’ve lost with our lives, with our families, our health, our emotional health,” Thompson told reporters outside court.
“My prayer is that this mesh would be banned and that no woman would suffer what we suffer.”
Attorney Jan Saddler of Shine Lawyers, the firm representing the women, said the major problem with the devices is that they erode into surrounding tissue and organs, causing a chronic inflammatory response. Virtually all the women involved in the lawsuit suffer chronic pain, and many have experienced relationship problems due to their inability to have sex, Saddler said.
“Many women are no longer able to have any sort of sexual relationship, or if they are able to have a sexual relationship, there is a lot of pain associated with that,” Saddler said.
“Women have been also unable to really enjoy proper fulfilling relationships not only with their partners, but with their children, with their friends.
“Women have found it very difficult to work in the way they used to work. So it’s had really debilitating impacts.”
Johnson & Johnson says it has sold over 100,000 mesh products in Australia. The lawsuit singles out nine separate devices; of those, the company has taken five off the market.
None of the devices have been subject to a recall by Australian regulators. In the US, the Food and Drug Administration last year reclassified all pelvic mesh implants as “high risk” instead of moderate, making them subject to extra regulatory requirements. But the agency has not recalled the devices.
In a statement, Johnson & Johnson said the use of mesh to treat pelvic organ prolapse and urinary incontinence has successfully helped millions of women worldwide, and said the majority of women who undergo the surgery have had a positive result.
- About Us
- |
- Terms of Use
- |
-
RSS
- |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证:沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证:31120180004
- |
- 网络视听许可证:0909346
- |
- 广播电视节目制作许可证:沪字第354号
- |
- 增值电信业务经营许可证:沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.